However, oral administration of buspirone significantly reduced IS-induced anxiety-/depression-like behaviors and suppressed IL-1β and TNF-α expression and NF-κB+/Iba1+ cell population in the hippocampus (Fig. 1A–G, Supplementary Fig. S1A). Here, TNF is linked to depressive symptom measurement.